Lyka Labs to raise funds upto Rs 100 crore

28 Dec 2015 Evaluate

Lyka Labs has decided to raise funds upto Rs 100 crore by way of issue of shares on Preferential basis/Qualified Institutional Placement (QIP)/convertible debentures and any other securities in one or more combination. The company has also decided to increase Authorized Capital from existing Rs 26 crore consisting of Equity Capital of Rs 24 crore and Preference Capital of Rs. 2 crore to Rs 32 crore consisting of Equity Capital of Rs 30 crore and Preference Capital of Rs 2 crore.

The board of company at its meeting held on December 28, 2015 has approved for the same. An Extra Ordinary General Meeting of members of the Company is convened on January 21, 2016 to obtain approval of Shareholders to authorize the Board of Directors to alter capital clause of Memorandum of Association of the Company and to decide the mode, size and terms & conditions of issue of capital.

Lyka Labs is engaged in the manufacture of pharmaceutical products. It also manufactures Veterinary products including injections, powders, creams and suspensions. The company offers various surgical disposables, such as syringes, surgical blades, cotton crepe bandage and first aid kits.

Lyka Labs Share Price

78.32 -2.72 (-3.36%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×